2019 | Tumor clonal status predicts clinical outcomes of lung adenocarcinoma with EGFR-TKI sensitizing mutation
| Journal of Cancer |
2019 | Tumor doubling time predicts response to sorafenib in radioactive iodine-refractory differentiated thyroid cancer
| Endocrine Journal |
2022 | Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib) | CLINICAL CANCER RESEARCH |
2021 | Tumor Glucose Metabolism and Its Heterogeneity on F-18 FDG PET/CT Provide Better Prognostication in Nonmetastatic Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma
| CANCERS |
2009 | Tumor heterogeneity of FIGO stage III carcinoma of the uterine cervix | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2020 | Tumor Immune Microenvironment in Cancer Patients With Leukocytosis | CANCER IMMUNOLOGY IMMUNOTHERAPY |
2013 | Tumor Lesion Diameter on Diffusion Weighted Magnetic Resonance Imaging Could Help Predict Insignificant Prostate Cancer in Patients Eligible for Active Surveillance: Preliminary Analysis | JOURNAL OF UROLOGY |
2004 | Tumor localization using laparoscopic ultrasound for a small submucosal tumor | JOURNAL OF SURGICAL ONCOLOGY |
2011 | Tumor margin histology predicts tumor aggressiveness in papillary thyroid carcinoma: a study of 514 consecutive patients
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2011 | Tumor markers in fine-needle aspiration washout for cervical lymphadenopathy in patients with known malignancy: preliminary study | AMERICAN JOURNAL OF ROENTGENOLOGY |
2016 | Tumor mesenchymal stem-like cell as a prognostic marker in primary glioblastoma
| Thesis |
2016 | Tumor mesenchymal stem-like cell as a prognostic marker in primary glioblastoma
| STEM CELLS INTERNATIONAL |
2014 | Tumor MET expression profile predicts the outcome of non-small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitors | THORACIC CANCER |
2019 | Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation | Science |
2023 | Tumor microbiome analysis provides prognostic value for patients with stage III colorectal cancer
| FRONTIERS IN ONCOLOGY |
2019 | Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function
| JOURNAL FOR IMMUNOTHERAPY OF CANCER |
2019 | Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade | CLINICAL CANCER RESEARCH |
2022 | Tumor microenvironment-aware, single-transcriptome prediction of microsatellite instability in colorectal cancer using meta-analysis
| SCIENTIFIC REPORTS |
2019 | Tumor Mutational Burden and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
| CANCERS |
2021 | Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions
| CANCERS |